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The California serogroup is composed of antigenically and biologically related viruses within the Bunyavirus genus of the
Bunyaviridae. We used a large panel of murine cells to study their tissue tropisms and found virtually identical patterns of
viral replication among all of the members of this serogroup, in contrast to other members of the family (Bunyamwera,
Cache Valley, and Punta Toro viruses). By analyzing the nonpermissive infections with both an RNA dot-blot and a virus
binding assay, we determined that tropism for cultured cells was determined at the level of entry. A truncated soluble form
of the La Crosse G1 glycoprotein (sG1) was expressed in a baculovirus system and, despite slight differences in glycosylation,
was shown to resemble native G1 by immunoprecipitation with six monoclonal antibodies. sG1 bound to permissive but
not to nonpermissive cell lines, as demonstrated by flow cytometry. The sG1 effectively blocked infection of permissive cell
lines with all of the California serogroup viruses, but did not block infection of two other bunyaviruses. These results indicate
that the California serogroup bunyaviruses share a common receptor on vertebrate cells which may differ from the receptor
used by other Bunyaviridae and demonstrate that the G1 glycoprotein is the virus attachment protein. sG1 will be a useful
reagent in the search for a putative receptor molecule. q 1995 Academic Press, Inc.
INTRODUCTION excellent model for the pathogenesis of this encephalitis
(Johnson and Johnson, 1968). Taking advantage of the
The California serogroup is composed of 12 serologi- segmented LAC genome, the mouse model has been
cally related viruses which form a subgroup within the used to analyze the genetics of viral neuroinvasiveness
Bunyavirus genus of the family Bunyaviridae (Hammon and virulence (Janssen et al., 1986; Griot et al., 1993,
and Reeves, 1952; Kappus et al., 1983; Campbell et al., 1994a) and to define the role of the glycoproteins in gen-
1992). Although the original isolate of the subgroup was erating a protective immune response (Pekosz et al.,
California encephalitis (CE) virus, La Crosse (LAC) virus 1995). The cellular receptor for either LAC virus or any
is medically more important, at least in North America, other bunyavirus has not been identified.
and it has been studied more extensively in recent years. Previous studies utilizing monoclonal antibodies di-
Like all of the Bunyaviridae, members of the California rected against the G1 glycoprotein of LAC virus have
serogroup have a tripartite negative-stranded RNA ge- implicated it as the viral attachment protein since these
nome consisting of large (L), middle-size (M), and small monoclonal antibodies were able to inhibit virus hemag-
(S) segments, which encode the L or polymerase protein,
glutination and binding of radiolabeled virus to BHK-21
the glycoproteins G1 and G2, and the N or nucleocapsid
cells (Gonzalez-Scarano et al., 1982; Grady et al., 1983;
proteins, respectively (Cabradilla et al., 1983; Clewley et
Kingsford et al., 1991). Furthermore, proteolytic degrada-
al., 1977; Eshita and Bishop, 1984; Roberts et al., 1995).
tion of G1 with trypsin or pronase virtually eliminated theTwo nonstructural proteins of unknown function are also
ability of LAC to bind to vertebrate but not invertebrateencoded, one each in the M and S segments.
cells (Ludvig et al., 1991). However, protease treatmentLAC virus is a common cause of pediatric encephalitis
of the closely related California encephalitis virus elimi-in those areas of the midwestern USA that are the princi-
nates infectivity on both types of cells (Hacker et al.,pal breeding sites for its main mosquito vector, Aedes
1995). The role of G2 in attachment to vertebrate cells istriseriatus (Parkin et al., 1972; Thompson and Evans,
not understood at this time, but antibodies to G2 appear1965; Artsob, 1983). Newborn laboratory mice provide an
to neutralize virus in a mosquito cell line, but not in verte-
brate ones (Ludvig et al., 1991), although anti-G1 antibod-
ies protect mosquitoes from LAC infection (Hacker et al.,1 Present Address: Institute of Virology and Immunoprophylaxis,
Swiss Federal Veterinary Office, CH-3147 Mittelha¨usern, Switzerland. 1995). We undertook these studies as a first step toward
2 To whom correspondence and reprint requests should be ad- defining the relationship between tissue tropism and re-dressed at Department of Neurology, Clinical Research Building, 415
ceptor binding and to advance our understanding of theCurie Boulevard, Philadelphia, PA 19104-6146. Fax: (215) 573-2029. E-
mail: Scarano@mail.med.upenn.edu. interrelationships among members of the Bunyaviridae.
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California serogroup viruses replicate in most cultured have been described (Janssen et al., 1984). Snowshoe
hare, Tahyna B92, Trivitattus (TVT), CE, Inkoo, Jamestownmurine cells, but three cell lines derived from lymphoid
tissue showed no evidence of viral replication after expo- Canyon, Melao, Keystone, Bunyamwera (BUN), Cache
Valley (CAV), and Punta Toro (PT) were a gift from R.sure to LAC virus. With a single exception, this pattern
was reproduced by the other members of the serogroup, Shope, Yale Arbovirus Research Laboratory (New Haven,
CT). Working stocks of all viruses were prepared andalthough not by other representative Bunyaviridae, indi-
cating a pattern of tissue culture tropism common to the titrated in BHK-21 cells.
To prepare radiolabeled LAC (35S-LAC), BHK-21 cellsantigenically related viruses of the CE serogroup. Again
using LAC as the model, we determined that the absence were grown to near confluency in a 10-chamber cell fac-
tory (Nunc, Naperville, IL). LAC virus was added at anof viral replication was not the result of an abortive infec-
tion, as we could not detect transcription of viral RNA approximate multiplicity of infection (m.o.i.) of 0.01 plaque
forming units (PFU)/cell (in a total volume of 200 ml) inafter exposure of the nonpermissive cell lines to a large
inoculum. Furthermore, virus growth was correlated with methionine/cysteine-free media (EMEM Select-Amine
kit, Gibco BRL, Grand Island, NY). After a 30-min incuba-binding of 35S-labeled LAC to intact cells, suggesting that
the initial interaction with the cell surface receptors is tion period at room temperature, 600 ml of media con-
taining 10 mCi of an L-[35S]methionine and L-[35S]cysteinethe critical determinant of tropism.
A recombinant, truncated form of the LAC G1 protein mixture (35S-Trans label, ICN Biomedicals, Irvine, CA)
was added, and the cell factory was incubated at 337(sG1) prepared in a baculovirus system (Pekosz et al.,
1995) was then used as a probe to define G1 as the virus until 90% of the cells showed cytopathic effect (3–4
days). The radiolabeled virus was purified with a sucroseattachment protein. sG1 differed from the native LAC G1
in its glycosylation pattern, but it reacted with a panel of gradient as described (Janssen et al., 1986), resus-
pended in PBS, aliquoted at 5000 cpm/ml, and stored atLAC G1 specific monoclonal antibodies that recognize
conformation-dependent epitopes. Pretreatment of mu- 0707 until used. Each 35S-LAC preparation was analyzed
by SDS–PAGE and found to contain virtually no nonviralrine neuroblastoma cells with this recombinant sG1 pro-
tein resulted in a marked decrease in replication of all proteins.
of the CE group viruses, but had no effect on the replica-
tion of representative bunyaviruses outside the sero-
Virus replication
group.
These results indicate that G1 is the attachment pro- Monolayer cells were plated on 24-well plates (Nunc,
tein for the CE viruses in vertebrate cell lines and suggest Naperville, IL) at approximately 105 cells/well, grown
that viruses in the California serogroup share a receptor overnight, and incubated with virus at m.o.i. 0.01 or 1.0
that is distinct from that used by some other bunyavi- for 30 min. Plaque titers of the supernatants were deter-
ruses. mined in BHK-21 cells, as described (Janssen et al.,
1984), with a limit of detection of 101.7 PFU/ml. sG1 inhibi-
MATERIALS AND METHODS tion of bunyavirus replication was determined by first
incubating the cells with rBac sG1 supernatant for 1 hrCells
at 47 prior to the addition of virus.
BHK-21 cells were grown in minimum essential me-
dium with Earle’s salts (MEM; JRH Biosciences, Lenexa,
Dot-blot analysisKS) supplemented with 5% fetal bovine serum (FBS;
Gibco, Grand Island, NY) and 5% horse serum (Hyclone,
Cytoplasmic RNA from 106 LAC-infected cells (m.o.i.
Logan, UT). C1300NA, P388D1, J774A.1, and EL-4 were
10) was extracted by disruption of pelleted cells in TE
grown in Dulbecco’s modified eagle medium (DMEM;
buffer (pH 7.6) containing 0.1% Nonidet P-40. The mix-
Gibco BRL, Grand Island, NY) supplemented with 10%
ture was incubated on ice for 5 min, pelleted at 15,000
FBS. C2C12 cells were grown in DMEM with 15% FBS.
g for 5 min at 47, and 50 ml of the supernatant was
These cell lines were all maintained at 377 in a 5% CO2 mixed with 20 ml 37% formaldehyde and 0.5 ml 201
incubator. Sf9 cells were grown in a 1:1 mixture of Sf900II
SSC, mixed well, and stored at 0707 until use. The pro-
media (Gibco BRL, Grand Island, NY) and Grace’s media
cedures for detection of LAC S RNA have been de-(Gibco BRL, Grand Island, NY) with 10% FBS, and penicil-
scribed (Endres et al., 1989). Briefly, a 600-bp PstI re-lin/streptomycin (Gibco BRL, Grand Island, NY), at 287 in
striction enzyme fragment from plasmid LAC 4C-26 (Ca-spinner flasks. Hy5 cells were grown at 287 in Sf900II
bradilla et al., 1983) was purified using GeneClean IImedia alone.
(BIO 101 Inc., La Jolla, CA) and labeled with [a-32P]ATP
using the random priming method according to the man-Bunyaviruses
ufacturers’ instructions (Boehringer-Mannheim, India-
napolis, Indiana). This probe can detect viral RNA inThe derivation and characterization of La Crosse/origi-
nal (LAC) and the mouse brain passaged Tahyna 181/57 either the genomic or the antigenomic sense.
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Virus binding assay incubated for 18 hr at 377, 21 SDS–PAGE sample buffer
was added, and the samples were boiled for 5 min before
Monolayer cells were seeded in 24-well plates at 105 analysis by SDS–PAGE. All enzymes were purchased
cells/well, grown overnight, and the medium was re- from Boehringer-Mannheim.
moved, replaced with PBS with 5% bovine serum albumin
(Sigma, St. Louis, MO), and the cells were then chilled Binding of sG1 to cells: FACS
at 47 for 15 min. The monolayers were incubated on ice
C1300NA cells were suspended by treatment with PBSfor varying periods of time with 37,500 cpm of 35S-LAC/
containing 5 mM EDTA for 10 min, and aliquots of 106 ofwell (specific activity, 1– 5 1 105 cpm/mg of viral protein),
these or EL-4 cells placed in 12 1 75-mm tubes. Thewashed three times with ice-cold PBS, lysed in 1% SDS in
cells were then incubated with either LAC- or baculovi-water, and finally counted in scintillation vials containing
rus-infected cell supernatants for 1 hr at 47, fixed withScintiverse BD scintillation fluid (Fisher Scientific, Fair-
4% paraformaldehyde for 10 min, washed, blocked inlawn, NJ). In experiments where antibodies to the LAC
PBS with 10% FBS for 30 min, resuspended in an anti-glycoproteins were used to inhibit 35S-LAC binding, the
G1 MAb cocktail (diluted 1:50 in PBS with 10% FBS), andvirus was preincubated with antibody for 1 hr at room
incubated at 47 for 1 hr. They were washed twice in PBStemperature before transferring the mixture to the cell
with 10% FBS and incubated with FITC-conjugated goatmonolayers. Suspension cells were diluted to 1–5 1
anti-mouse IgG to (diluted 1:50 in PBS with 10% FBS;105 cells/ml, aliquoted in microcentrifuge tubes, and LAC
Cappel, Organon Teknika, Durham, NC) for 1 hr at 47.binding was assayed in the same manner.
The samples were washed three times and stored in 2%
paraformaldehyde until analysis by flow cytometry.Recombinant baculovirus supernatants
Protocols for the construction and preparation of rBac-
RESULTS
sG1, rBac gp120 (which expresses the gp120 glycopro-
tein from human immunodeficiency virus type 1), bac- Replication of LAC and other bunyaviruses in murine
gD2 (which expresses a transmembrane/cytoplasmic tail cell lines
truncated form of the gD glycoprotein from herpes sim-
We screened a number of cell lines from different tis-plex virus type 2), and wild-type baculovirus Autographa
sues and species for their ability to support LAC viruscalifornica nuclear polyhedrosis virus (AcNPV) have been
replication. The virus replicated well in murine cell linespreviously described (Pekosz et al., 1995; Nicola et al.,
of muscle (C2C12), fibroblastic (NIH3T3), and neuralmanuscript in preparation). Cell supernatants were pre-
(C1300NA) origin (Table 1, data not shown, and Griot etpared by infecting Sf9 cells at m.o.i. 10 for 1 hr, removing
al., 1994b) as well as in our reference cell line, babythe inoculum, adding fresh media, and incubating at 287
hamster kidney cells (BHK-21). There was no evidencein a spinner flask for 72 hr. Cellular debris were pelleted
of replication in three murine cell lines of lymphoid originby centrifugation at 500 g for 10 min and the supernatants
(P388D1, J774A.1, and EL-4) nor in primary murine mono-were aliquoted and stored at 0207.
cyte-derived macrophages (data not shown). These re-To prepare 35S-labeled sG1 (35S-sG1), cells were in-
sults were consistent with pathogenesis experimentsfected as described above, plated onto six-well plates
that have indicated a plasma, but not a lymphoid cell-(Costar, Cambridge, MA), and grown at 287 for 24 hr. The
associated viremia (Janssen et al., 1984, 1986), and sug-medium was then replaced with methionine/cysteine-
gested that further investigation of the lymphoid cell linesfree medium containing 0.2 mCi of 35S-Trans label/ml and
could provide insight into the mechanisms for viral re-incubated at 287 for an additional 48 hr before harvesting.
striction in those cells.Serum samples from mice that survived a LAC challenge,
California serogroup viruses are serologically relatedor individual monoclonal antibody (MAb) ascites fluids
and genetically compatible, as reassortant viruses have(both at a 1:10 dilution), were used to immunoprecipitate
been prepared using several combinations of strainsand analyze 35S-sG1 or 35S-LAC as described (Pekosz et
(Gentsch and Bishop, 1976; Gentsch et al., 1979, 1980).al., 1995).
Thirteen viruses from the California serogroup as well
as other bunyaviruses were then tested for replication inDeglycosylation of sG1
the panel of cell lines (Table 1). The California serogroup
viruses had the same host range, since with the excep-A mixture of anti-G1 MAbs was used to immunoprecip-
itate 35S-sG1 or 35S-LAC. Protein A–Sepharose beads tion of TVT, which replicated in the EL-4 line, none of
the viruses replicated in lymphoid cells. To determinewith bound sG1 were suspended in either 50 mM sodium
phosphate buffer, pH 7.0, for deglycosylation with endo- whether this pattern was characteristic of other Bunyavir-
idae, we used three additional viruses: BUN and CAVglycosidase H (20 mU) or N-glycosidase F (20 mU), or in
50 mM sodium acetate, pH 5.2, for deglycosylation with are serologically unrelated viruses from the same genus
as LAC virus, and PT is a member of the Phlebovirusneuraminidase (Vibrio cholerae, 50 mU), O-glycanase (2
mU), or combinations of enzymes. The samples were genus. All of these viruses exhibited a strikingly different
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TABLE 1
California Serogroup Viruses Display a Similar in Vitro Cell Tropism
Cells
Viruses Permissive Nonpermissive
Genus Group Strain BHK-21 C1300NA P388D1 J774A.1 EL-4
Bunyavirus California California encephalitis 5.0a 5.8 — b — —
La Crosse 8.0 8.0 — — —
Snowshoe hare 8.0 8.0 — — —
Tahyna B92 7.9 5.8 — — —
Tahyna 181/57 8.0 8.0 — — —
Inkoo 7.9 5.4 — — —
Melao 7.0 5.8 — — —
Keystone 8.0 6.9 — — —
Jamestown Canyon 8.0 7.0 — — —
Trivitattus 7.8 6.9 — — 5.2
Bunyamwera Bunyamwera 7.0 6.9 5.9 3.8 2.8
Cache Valley 5.7 4.3 4.7 2.5 2.8
Phlebovirus Punta Toro Punta Toro 8.0 7.0 5.8 4.8 4.4
a Titers of infected cell supernatants 72 hr after infection, expressed as log10 PFU/ml. m.o.i. ⁄ 1 PFU/cell.
b —, titers below the detection limit of the plaque assay (1.7 log10 PFU/ml).
pattern of replication, as they productively infected all of when the binding assay was performed on permissive
NIH 3T3, C2C12 (myoblasts), mouse L-cells (data notthe cell lines tested, including the lymphoid lines.
shown), and C1300NA cells (see below). Brief trypsin
LAC transcription in permissive and nonpermissive treatment of the cells abolished virus binding (Fig. 2)
cell lines without affecting cell viability.
To test the specificity of the assay, a panel of MAbsTo search for a block in entry an additional experiment
directed against the viral glycoproteins was used to in-was performed. The three nonpermissive lines were in-
hibit LAC binding to BHK-21 cells. As shown in Table 2,fected at a high multiplicity (m.o.i. 10). Total cytoplasmic
either a mixture of anti-G1 antibodies or antibodies 807-RNA was harvested at time points ranging from 1 to 12
31, 807-33, and 807-25 were highly effective at blockinghr after infection and then hybridized with a probe derived
binding. Antibodies against G2 or N, as well as somefrom the S RNA segment, which should be the most
other antibodies against G1 (including neutralizing MAbabundant LAC-specific RNA during the early steps of
807-35), demonstrated no binding inhibition. We werereplication (Rossier et al., 1988). There was no evidence
unable to compete the 35S-labeled virus with unlabeledof viral transcription in any of the nonpermissive
LAC, presumably because maximum titers with LAC arelymphoid cell lines, in comparison with permissive cell
only108 PFU/ml and not sufficient to block a detectablelines such as BHK-21 or C1300NA (Fig. 1). These results
number of the binding sites on the permissive cells.demonstrated that the block to viral replication occurred
Virus binding assays were then performed with theat or prior to primary transcription of the viral genome
replication-negative cell lines J774A.1, P388D1, and EL-and strongly suggested that it was during the steps of
4 and are shown in Fig. 3. The three nonpermissive cellbinding or entry of the virus.
lines demonstrated only low levels of binding of 35S-la-
beled LAC compared to permissive C1300NA cells,LAC binding to permissive and nonpermissive
which showed binding comparable to that of BHK-21cell lines
cells. Together, these results indicated that cellular tro-
To determine whether the block to replication in the pism for LAC virus is determined at the level of virus
lymphoid cells was due to the absence of a cellular re- binding and entry.
ceptor for the virus, a binding assay was developed in
our reference cell line, BHK-21. Metabolically labeled vi- Expression and characterization of a truncated LAC
rus was incubated with ice-cold cells, and cell-associ- G1 (sG1)
ated counts were assayed at intervals up to 120 min.
Figure 2 shows a representative experiment where bind- To investigate the role of the G1 glycoprotein in LAC
virus entry, we constructed a recombinant baculovirusing reached 20% of input. Similar results were obtained
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TABLE 2
Inhibition of LAC Binding to BHK-21 Cells
by Monoclonal Antibodies
Antibody Specificity a % Bindingb
None 100
807-31 G1 (neutralizing) 10
807-33 G1 (neutralizing) 33
807-25 G1 (nonneutralizing) 35
807-17 G1 (nonneutralizing) 50
813-13 G1 (neutralizing) 70
807-27 G1 (nonneutralizing) 78
807-35 G1 (neutralizing) 95
9B7.5 G2 (nonneutralizing) 95
814-87 N 98
W6-32 Human MHC class I 92
Anti-G1 mixturec G1 7
a Specificity of these antibodies has been described before (Gonza-
lez-Scarano et al., 1982; Najjar et al., 1985). W6-32 was used as an
irrelevant MAb. Experiments representative of two experiments with
BHK-21 cells and two experiments with C2C12, a murine muscle cell
line. All experiments were performed with either ascites fluids or ammo-
FIG. 1. Dot-blot hybridization of La Crosse virus-infected cells. Ap- nium sulfate precipitated hybridoma cell supernatants.
proximately 106 cells were inoculated with LAC (m.o.i. 10) and cyto- b Calculated as [(cpm bound without antibody) 0 (cpm bound with
plasmic RNA was extracted at the intervals indicated and hybridized antibody)/cpm bound without antibody]1 100 (see Materials and Meth-
with an S RNA segment 32P-labeled probe (see Materials and Methods). ods).
BHK-21 (hamster kidney) and C1300NA (murine neuroblastoma) cells c Consists of equal parts (v/v) of 807-31, 807-33, and 807-35.
are permissive for LAC. P388D1 (murine monocyte–macrophage),
J774A.1 (murine monocyte– macrophage), and EL-4 (mouse T-
lymphoma) are all nonpermissive for La Crosse and had no evidence
immunoprecipitated with a panel of antibodies raisedof viral transcription after exposure to virus.
against native G1 (Fig. 4a). sG1 was recognized by six
individual anti-G1 MAbs from distinct subgroups (Najjar
which expressed a truncated form of the LAC G1 protein et al., 1985) directed against conformational epitopes (J.
(sG1) under the control of the mellitin signal peptide (Pek- Fazakerley, unpublished results). Furthermore, the sG1
osz et al., 1995). To assess its conformation, sG1 was signal obtained by immunoprecipitation with each of the
MAbs was roughly equivalent to that obtained by immu-
noprecipitation with polyclonal anti-LAC mouse serum.
These data indicated that sG1 is recognized by MAbs
directed against conformational epitopes on the G1 pro-
tein of LAC virus.
We then compared the glycosylation pattern of sG1
with that of native LAC G1 prepared from virus grown in
mammalian cells. The glycoproteins were immunopre-
cipitated with an anti-G1 MAb cocktail, incubated with
various glycosidases, and analyzed by SDS–PAGE (Fig.
4b). The contribution of sugars to the apparent molecular
weight of sG1 was less than that of LAC G1 (compare
the mobility of proteins treated with a combination of
enzymes in lanes 6 with untreated proteins in lanes 1).
This difference may be attributed to the composition of
N-linked carbohydrates, since treatment with N-glyca-
FIG. 2. La Crosse virus binds BHK-21 cells. La Crosse virus was nase-F led to a clear shift in mobility of the native LAC
metabolically labeled with [35S]methionine, and a binding assay per-
G1 but not of sG1 (Fig. 4b, lanes 1 and 3). Neither proteinformed as indicated under Materials and Methods. Binding is ex-
appeared to shift its mobility when either sialic acid (Fig.pressed as cell-associated cpm 0 nonspecific counts on vessel/total
input counts 1 100 at the indicated time point in the reaction (circles). 4b, lanes 4) or O-linked carbohydrates (Fig. 4b, lanes 5)
These data are averages of duplicate wells and representative of three were removed. Treatment of LAC G1 with endoglycosi-
separate experiments, where the input cpm were in the range 25,000–
dase H (endoH) showed that some of the native G1 re-35,000 cpm/105 cells. Pretreatment of the cells with trypsin led to a
mained sensitive to endoH (Fig. 4b, lanes 2), while themarked diminution in LAC virus binding without affecting cell viability
(squares). sG1 had no band shift after treatment, implying that all
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proteins might be more comparable in their glycosylation
patterns when they are both grown in invertebrate cell
lines.
Binding of sG1 to C1300NA cells: FACS
We then determined whether sG1 could bind to a LAC
virus permissive cell line, C1300NA, with an assay based
on flow cytometry (see Materials and Methods). As
shown in Fig. 5, there was a clear signal obtained with
sG1 or LAC virus-treated cells. A number of controls were
used to confirm the specificity of this binding. sG1 did
not bind the nonpermissive EL-4 cells and binding be-
tween sG1 and C1300NA cells was specifically inhibited
by a polyclonal anti-LAC serum (Table 3). This assay was
also performed with ELISA, with similar results (data not
shown). Taken together, these results indicate that sG1
is an effective surrogate for the binding of native LAC
virus G1, in spite of the slight differences in its glycosyla-
tion pattern.
Bunyavirus infection inhibition by sG1
To determine whether sG1 could interfere with infec-
tion of C1300NA cells, we performed experiments in
which the cells were pretreated with baculovirus super-
natants prior to infection with several bunyaviruses. The
experiment shown in Fig. 6 demonstrates a 1000-fold
reduction in LAC virus replication in cells pretreated with
baculovirus supernatant containing sG1, in contrast to
FIG. 3. La Crosse binding to permissive and nonpermissive murine
cells pretreated with either wild-type AcNPV or bac-gD2cells. Metabolically labeled virus was bound to either permissive
(see Materials and Methods). However, sG1 had no ef-(C1300NA) cells or nonpermissive lymphoid cells and cell-associated
cpm were determined as a percentage of total counts, as indicated fect on infection with Bunyamwera virus.
under Materials and Methods, after subtraction of nonspecific binding Several experiments were performed to determine the
in the absence of cells. These data are averages of duplicate wells point at which sG1 was inhibiting infection. To rule out
and representative of two or three experiments with each cell line. The
the formation of a LAC–sG1 complex that could poten-input cpm were in the range 25,000–35,000 cpm/105 cells.
tially interfere with entry, radiolabeled sG1 was incu-
bated with LAC, and the mixture pelleted in a 20% su-
crose cushion. The sG1 remained at the top of the su-of the secreted sG1 had complex carbohydrate modifica-
tions. We did not compare sG1 with native LAC G1 pro- crose solution, as opposed to LAC, which was recovered
from the pellet (data not shown). To confirm that sG1duced in mosquito cells, another host for LAC; these
FIG. 4. (a) Immunoprecipitation of sG1 with MAbs. 35S-labeled La Crosse (first two lanes) or sG1 (all remaining lanes) were immunoprecipitated
with mouse anti-La Crosse serum (MaL) or normal mouse serum (NMS). sG1 was also immunoprecipitated with anti-G1 MAbs: 1, 807-15; 2, 807-
31; 3, 807-35; 4, 807-22; 5, 807-25; 6, 807-26. The positions of native G1 and sG1 are indicated by the arrows to the right. sG1 was recognized by
all six conformation-dependent MAbs. Heat-denatured sG1 was not recognized by any of the antibodies (not shown). (b) Endoglycosidase digestion
of La Crosse G1. 35S-labeled La Crosse G1 or sG1 were immunoprecipitated and digested with the following glycosidases: 1, undigested; 2,
endoglycosidase H; 3, N-glycosidase F; 4, neuraminidase; 5, neuraminidase and O-glycanase; 6, neuraminidase, O-glycanase and N-glycosidase
F. There were minor differences between the glycosylation patterns of the native G1 and sG1.
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FIG. 5. Binding of sG1 to C1300NA cells. Supernatants from La Crosse- or rBac sG1-infected cells were incubated with C1300NA cells as
described under Materials and Methods, and the bound virus or sG1 in 104 cells was detected with a combination of murine anti-G1 MAbs followed
by FITC-conjugated goat anti-mouse IgG. The mean channel fluorescence values of control proteins treated similarly are listed in Table 3. There
was no significant binding to nonpermissive EL-4 cells (Table 3).
inhibition was at the level of LAC virus entry, cells were We then performed sG1 inhibition experiments with
the 13 California serogroup bunyaviruses as well as 3treated with sG1 at 1 hr before or 3 hr after infection with
LAC (Fig. 7). Treatment with sG1 1 hr before infection serologically unrelated bunyaviruses (Table 4). All of the
members of the California serogroup were sensitive toresulted in decreased virus titers at all time points, when
compared to cells that were untreated or were treated 3 sG1, with at least 100-fold reductions in peak titer. Repli-
cation was barely detectable with Tahyna B92, Inkoohr following infection with LAC virus. The latter had an
intermediate effect, as see in Fig. 7. and Trivittatus. In contrast, sG1 had no effect on the
replication of Bunyamwera or Punta Toro viruses. Sur-
prisingly, sG1 inhibited infection by Cache Valley virus,TABLE 3
even though its pattern of cellular tropism resembled
sG1 Binds to Permissive C1300NA Cells Bunyamwera and Punta Toro.
but Not to Nonpermissive EL-4 Cells
Mean channel fluorescence DISCUSSION
Cells Liganda 0 background
We have shown that members of the California sero-
C1300NA AcNPV 0 group exhibit similar in vitro tropism for a panel of cell
La Crosse 416
lines and differ from a small sample of other memberssG1 127
of the Bunyaviridae. Using LAC virus as a model, wesG1 / anti-LAC 43
sG1 / NRS 220 noted that viral replication was correlated with virus bind-
gp 120 3 ing and that the nonpermissive lines showed no evi-
gD-2 21 dence of viral transcription. These and the results with
EL-4 AcNPV 0 sG1 indicate that virus binding and entry account for
La Crosse 17 the cellular tropisms and suggest that members of the
sG1 14 California serogroup utilize a common receptor molecule
that is not present in lymphocytic/monocytic cells. Sincea 10,000 C1300NA or EL-4 cells were treated with ligand (LAC or
these viruses are genetically and antigenically relatedbaculovirus-infected cell supernatant) at 47, stained with anti-G1 MAb
and FITC-conjugated goat anti-mouse IgG secondary antibody, fixed, (Gonzalez-Scarano et al., 1982; Kingsford et al., 1983;
and analyzed by FACS. AcNPV, wild-type baculovirus, was used as Kingsford and Boucquey, 1990), this finding is not totally
negative control, and its signal considered background; gp120 and gD- surprising. Less expected were the results that viruses
2 were prepared in the same baculovirus system; anti-LAC is a poly-
either from the same genus (Bunyamwera, Cache Valleyclonal anti-LAC serum prepared in rabbit: NRS, Normal rabbit serum.
viruses) or from a different genus within the same familyThese data are representative of three experiments with the NA cells
and two experiments with the EL-4 cells. (Punta Toro virus) replicated in cells that were not per-
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FIG. 7. Effect of sG1 treatment before or after La Crosse virus infec-
tion. C1300NA cells were treated with rBac sG1 supernatant for 1 hr
on ice at 1 hr before or 3 hr after infection with La Crosse virus at
m.o.i. 0.01. Inhibition with sG1 was more efficient when the cells were
treated before LAC infection. Cells treated 3 hr after infection had an
intermediate pattern, suggesting inhibition of subsequent rounds of
infection.
defect in its fusion function. This suggested that there are
similarities in the entry process in these representativeFIG. 6. Inhibition of viral replication by sG1. Ice-cold C1300NA cells
hosts.were treated with baculovirus supernatants for 1 hr and then inoculated
with either Bunyamwera or La Crosse for 1 hr at m.o.i. 0.01, washed, Our results indicate that the G1 glycoprotein is the
and incubated at 337. Supernatants from the indicated intervals were viral attachment protein in infection of mammalian cells.
plaque-assayed in BHK-21 cells. rBac sG1, recombinant encoding sG1;
bac-gD2, recombinant encoding herpes simplex virus type 2 gD;
AcNPV, wild-type baculovirus. sG1 supernatant inhibited La Crosse TABLE 4
replication, but not Bunyamwera replication. The first point on the graph
Soluble G1 Inhibits the Replication of California Serogroup Virusesindicates that there was no inoculum left over at 6 hr postinfection; all
virus detected after that time was newly synthesized progeny virus.
Viruses Log10Pfu/mla
Change
missive for LAC. This argues for the existence of sepa- Genus Member AcNPV rBac sG1 (log10)
rate cellular receptors for the California serogroup and
Bunyavirus California 5.7 3.3 02.4other Bunyaviridae, although the results with Cache Val-
La Crosse 7.4 3.9 3.5ley were somewhat ambiguous, as sG1 inhibited its abil-
Snowshoe hare 6.9 3.7 03.2ity to infect C1300NA cells. Tahyna B92 5.0 1.7 ⁄03.3
LAC and other California serogroup viruses can infect Tahyna 181/57 6.1 3.0 03.1
Inkoo 4.0 1.7 ⁄02.3cell lines obtained from several species, and in vivo they
Melao 4.2 2.2 02.0infect mosquitoes and many small mammals (Yuill, 1983).
Keystone 5.9 3.6 02.3Thus, either the California serogroup receptor is a highly
Jamestown Canyon 5.0 2.7 02.3
conserved molecule that is present in many mammalian Trivitattus 5.8 2.0 03.8
and mosquito species or these viruses use several alter-
Bunyamwera 6.8 6.6 00.2bnate entry mechanisms, depending on the host species.
Cache Valley 4.3 2.6 01.7As the route of infection is quite different, involving direct
inoculation into subcutaneous tissue in the case of mam- Phlebovirus Punta Toro 5.7 5.5 00.2
mals and passage through the gut in mosquitoes, it is
a Cells were pretreated on ice with control baculovirus supernatantquite plausible that multiple cellular receptors are in fact
(AcNPV) or supernatant containing sG1 (rBac sG1) and then infectedrequired in the complex sylvatic biology of California se-
with each virus at m.o.i. 0.01. Seventy-two hours after infection, therogroup viruses. However, in one series of experiments, supernatant was titered on BHK-21 cells. These data are the geometric
a G1 MAb-selected LAC variant was attenuated for both mean of at least two independent experiments for each strain.
b Reductions less than 0.5 log10 were not considered significant.mice and mosquitoes (Sundin et al., 1987) and had a
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G1 is the major if not the exclusive target of neutralizing current experiments indicate that this is likely due to the
absence of a viral receptor on lymphoid cells. Closerantibodies (Gonzalez-Scarano et al., 1982; Grady et al.,
1983; Kingsford et al., 1983; Pekosz et al., 1995), and study of the receptor biology of California viruses is likely
to provide important insights into the pathogenesis ofseveral neutralizing anti-G1 MAbs were able to inhibit
binding of LAC virus to infectable cells. More directly, this group, and the sG1 is a useful reagent with which
to begin a search for putative cellular receptors.pretreatment of cells with sG1 decreased LAC replica-
tion. The inhibition of infection mediated by sG1 was
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